Bart De Spiegeleer
- Microbiology top 1%
- Antimicrobial Peptides and Activities 17
- Pharmaceutical Science top 1%
-
- Herbal Medicine Research Studies 18
- Spectroscopy top 2%
- Analytical Chemistry and Chromatography 29
- Analytical Chemistry top 1%
-
- Protein purification and stability 21
- Bacterial biofilms and quorum sensing 15
- Chemical Synthesis and Analysis 14
-
- Pharmaceutical Economics and Policy 12
-
- Neuropeptides and Animal Physiology 12
Bart De Spiegeleer
251 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 170
- Microbiology 442
- Pharmaceutical Science 339
- Complementary and alternative medicine 457
- Spectroscopy 509
- Analytical Chemistry 288
Countries citing papers authored by Bart De Spiegeleer
This map shows the geographic impact of Bart De Spiegeleer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart De Spiegeleer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart De Spiegeleer more than expected).
Fields of papers citing papers by Bart De Spiegeleer
This network shows the impact of papers produced by Bart De Spiegeleer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart De Spiegeleer. The network helps show where Bart De Spiegeleer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bart De Spiegeleer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 3 | |
| 5 | 2018 | 84 | |
| 6 | 2018 | 5 | |
| 7 | Poor dissolution of anthelminthic medicines : a risk for reduced efficacy | 2017 | 1 |
| 8 | Using Tc-99m-HMPAO SPECT as tool to compare two Transcranial Magnetic Stimulation protocols and their long-term effects in dogs | 2016 | 1 |
| 9 | 2016 | 8 | |
| 10 | The quality of paediatric medicines supplied by private wholesalers in Kinshasa, DRC | 2015 | 1 |
| 11 | 2015 | 9 | |
| 12 | Human skin kinetics of cyclic depsipeptide mycotoxins | 2014 | 2 |
| 13 | 2012 | 9 | |
| 14 | Skin penetration enhancing effect of the plant N-alkylamide spilanthol | 2012 | 1 |
| 15 | Development of a quorum-sensing peptide database: quorumpeps | 2011 | 1 |
| 16 | 2009 | 6 | |
| 17 | Pharmaceutical drugability of peptides | 2008 | 1 |
| 18 | Analytical characterisation of arsenic anticoccidials and their determination in poultry feed | 2006 | 2 |
| 19 | Distribution study of three-phase emulsions using confocal laser scanning microscopy (CLSM) | 2003 | 0 |
| 20 | Physical stability of diluted suspo-emulsions | 2002 | 0 |
About Bart De Spiegeleer
Bart De Spiegeleer is a scholar working on Pharmaceutical Science, Microbiology and Complementary and alternative medicine, having authored 261 papers that have together received 5.0k indexed citations. Recurring topics across this work include Analytical Chemistry and Chromatography (29 papers), Protein purification and stability (21 papers), Herbal Medicine Research Studies (18 papers), Antimicrobial Peptides and Activities (17 papers), Bacterial biofilms and quorum sensing (15 papers), Chemical Synthesis and Analysis (14 papers), Pharmaceutical Economics and Policy (12 papers) and Neuropeptides and Animal Physiology (12 papers). The work is most often cited by research in Microbiology (442 citations), Pharmaceutical Science (339 citations) and Complementary and alternative medicine (457 citations). Bart De Spiegeleer has collaborated with scholars based in Belgium, Netherlands and Ethiopia. Frequent co-authors include Evelien Wynendaele, Christian Burvenich, Kathelijne Peremans, Jente Boonen, Matthias D’Hondt, Christophe Van de Wiele, Nathalie Bracke, Bram Baert, Lien Taevernier and Bert Gevaert.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.